General Information of Drug Transporter (DT)
DT ID DTD0459 Transporter Info
Gene Name SLC6A7
Transporter Name Sodium-dependent proline transporter
Gene ID
6534
UniProt ID
Q99884
Epigenetic Regulations of This DT (EGR)

Methylation

  Colon cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in colon adenocarcinoma [ 1 ]

Location

5'UTR (cg07175433)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.35E+00 Statistic Test p-value: 2.51E-07; Z-score: -2.63E+00

Methylation in Case

3.97E-01 (Median) Methylation in Control 5.37E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in colon adenocarcinoma [ 1 ]

Location

TSS200 (cg02382400)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.26E+00 Statistic Test p-value: 1.64E-07; Z-score: 4.03E+00

Methylation in Case

6.61E-01 (Median) Methylation in Control 5.25E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in colon adenocarcinoma [ 1 ]

Location

Body (cg27323557)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 6.37E-04; Z-score: -2.97E+00

Methylation in Case

8.37E-01 (Median) Methylation in Control 8.87E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in pancretic ductal adenocarcinoma [ 2 ]

Location

5'UTR (cg03732506)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 1.93E-05; Z-score: -1.39E+00

Methylation in Case

5.86E-01 (Median) Methylation in Control 7.10E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in pancretic ductal adenocarcinoma [ 2 ]

Location

TSS1500 (cg14701893)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.64E-02; Z-score: -3.61E-01

Methylation in Case

8.69E-01 (Median) Methylation in Control 8.84E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in pancretic ductal adenocarcinoma [ 2 ]

Location

TSS1500 (cg24352530)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 3.62E-02; Z-score: -8.88E-01

Methylation in Case

1.98E-01 (Median) Methylation in Control 2.34E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A7 in pancretic ductal adenocarcinoma [ 2 ]

Location

TSS200 (cg03402876)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 1.04E-02; Z-score: -5.38E-01

Methylation in Case

9.07E-02 (Median) Methylation in Control 9.77E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A7 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg05414613)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 9.93E-16; Z-score: -2.03E+00

Methylation in Case

7.17E-01 (Median) Methylation in Control 8.02E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A7 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg04149930)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.25E+00 Statistic Test p-value: 2.83E-08; Z-score: -1.83E+00

Methylation in Case

6.66E-01 (Median) Methylation in Control 8.30E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A7 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg18677812)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.79E-06; Z-score: -3.54E-01

Methylation in Case

8.44E-01 (Median) Methylation in Control 8.52E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Bladder cancer

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in bladder cancer [ 3 ]

Location

TSS1500 (cg09588653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.96E+00 Statistic Test p-value: 7.87E-15; Z-score: -1.97E+01

Methylation in Case

3.98E-01 (Median) Methylation in Control 7.82E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in bladder cancer [ 3 ]

Location

TSS1500 (cg14778922)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.70E+00 Statistic Test p-value: 1.26E-11; Z-score: -1.07E+01

Methylation in Case

3.96E-01 (Median) Methylation in Control 6.74E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in bladder cancer [ 3 ]

Location

TSS1500 (cg09661503)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.16E+00 Statistic Test p-value: 4.59E-08; Z-score: -8.67E+00

Methylation in Case

7.66E-01 (Median) Methylation in Control 8.85E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A7 in bladder cancer [ 3 ]

Location

Body (cg15555712)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.02E+00 Statistic Test p-value: 3.03E-13; Z-score: -1.36E+01

Methylation in Case

3.50E-01 (Median) Methylation in Control 7.05E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A7 in bladder cancer [ 3 ]

Location

Body (cg02414785)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.48E+00 Statistic Test p-value: 3.74E-13; Z-score: -1.24E+01

Methylation in Case

2.39E-01 (Median) Methylation in Control 5.94E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A7 in bladder cancer [ 3 ]

Location

Body (cg22459052)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.95E+00 Statistic Test p-value: 7.36E-10; Z-score: -8.23E+00

Methylation in Case

2.81E-01 (Median) Methylation in Control 5.48E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A7 in bladder cancer [ 3 ]

Location

Body (cg21212995)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.79E+00 Statistic Test p-value: 1.27E-06; Z-score: -6.00E+00

Methylation in Case

1.61E-01 (Median) Methylation in Control 2.88E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A7 in bladder cancer [ 3 ]

Location

Body (cg11201401)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 4.25E-02; Z-score: 4.03E+00

Methylation in Case

4.53E-01 (Median) Methylation in Control 3.74E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A7 in bladder cancer [ 3 ]

Location

3'UTR (cg08631357)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.98E+00 Statistic Test p-value: 1.18E-11; Z-score: -1.13E+01

Methylation in Case

2.88E-01 (Median) Methylation in Control 5.72E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A7 in bladder cancer [ 3 ]

Location

3'UTR (cg18725599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 1.26E-03; Z-score: -3.44E+00

Methylation in Case

5.71E-01 (Median) Methylation in Control 6.47E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

TSS1500 (cg09588653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 1.97E-12; Z-score: -2.44E+00

Methylation in Case

6.66E-01 (Median) Methylation in Control 7.78E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

TSS1500 (cg09661503)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.26E-09; Z-score: -1.80E+00

Methylation in Case

8.61E-01 (Median) Methylation in Control 8.95E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

TSS1500 (cg14778922)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.43E+00 Statistic Test p-value: 4.92E-07; Z-score: -1.33E+00

Methylation in Case

4.62E-01 (Median) Methylation in Control 6.62E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

TSS200 (cg16843423)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.23E+00 Statistic Test p-value: 5.58E-04; Z-score: 3.88E-01

Methylation in Case

5.10E-02 (Median) Methylation in Control 4.15E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

Body (cg02414785)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 1.70E-18; Z-score: -2.92E+00

Methylation in Case

4.99E-01 (Median) Methylation in Control 6.39E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

Body (cg15555712)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.31E+00 Statistic Test p-value: 4.38E-16; Z-score: -3.65E+00

Methylation in Case

5.20E-01 (Median) Methylation in Control 6.80E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

Body (cg22459052)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.45E+00 Statistic Test p-value: 2.24E-14; Z-score: -2.63E+00

Methylation in Case

3.78E-01 (Median) Methylation in Control 5.46E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

Body (cg21212995)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.14E+00 Statistic Test p-value: 2.39E-05; Z-score: 1.57E+00

Methylation in Case

3.78E-01 (Median) Methylation in Control 3.32E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

Body (cg11201401)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.09E+00 Statistic Test p-value: 1.60E-04; Z-score: 1.04E+00

Methylation in Case

4.39E-01 (Median) Methylation in Control 4.03E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

3'UTR (cg08631357)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.34E+00 Statistic Test p-value: 3.05E-15; Z-score: -2.05E+00

Methylation in Case

4.54E-01 (Median) Methylation in Control 6.11E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC6A7 in breast cancer [ 4 ]

Location

3'UTR (cg18725599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 2.69E-02; Z-score: -6.42E-01

Methylation in Case

5.80E-01 (Median) Methylation in Control 6.10E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg09588653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 8.65E-09; Z-score: -3.60E+00

Methylation in Case

8.46E-01 (Median) Methylation in Control 9.38E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg09661503)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 2.44E-08; Z-score: -1.21E+01

Methylation in Case

9.07E-01 (Median) Methylation in Control 9.75E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in clear cell renal cell carcinoma [ 5 ]

Location

TSS200 (cg16843423)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 3.97E-03; Z-score: 2.05E-02

Methylation in Case

3.20E-02 (Median) Methylation in Control 3.18E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Colorectal cancer

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in colorectal cancer [ 6 ]

Location

TSS1500 (cg09588653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 2.14E-04; Z-score: 1.37E+00

Methylation in Case

8.39E-01 (Median) Methylation in Control 7.62E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in colorectal cancer [ 6 ]

Location

TSS1500 (cg14778922)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.19E+00 Statistic Test p-value: 1.40E-03; Z-score: 9.99E-01

Methylation in Case

6.94E-01 (Median) Methylation in Control 5.82E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in colorectal cancer [ 6 ]

Location

TSS1500 (cg09661503)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 3.39E-03; Z-score: 9.97E-01

Methylation in Case

8.91E-01 (Median) Methylation in Control 8.25E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A7 in colorectal cancer [ 6 ]

Location

TSS200 (cg16843423)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 5.42E+00 Statistic Test p-value: 4.45E-11; Z-score: 9.26E+00

Methylation in Case

1.59E-01 (Median) Methylation in Control 2.93E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A7 in colorectal cancer [ 6 ]

Location

Body (cg11201401)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.43E+00 Statistic Test p-value: 1.46E-18; Z-score: 4.13E+00

Methylation in Case

7.05E-01 (Median) Methylation in Control 4.92E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A7 in colorectal cancer [ 6 ]

Location

Body (cg21212995)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.32E+00 Statistic Test p-value: 5.40E-10; Z-score: 2.52E+00

Methylation in Case

4.99E-01 (Median) Methylation in Control 3.78E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A7 in colorectal cancer [ 6 ]

Location

Body (cg15555712)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.00E+00 Statistic Test p-value: 1.16E-02; Z-score: 5.84E-02

Methylation in Case

7.61E-01 (Median) Methylation in Control 7.59E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A7 in colorectal cancer [ 6 ]

Location

Body (cg02414785)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 2.91E-02; Z-score: -7.97E-01

Methylation in Case

7.75E-01 (Median) Methylation in Control 8.17E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A7 in colorectal cancer [ 6 ]

Location

3'UTR (cg08631357)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 4.10E-02; Z-score: -4.68E-01

Methylation in Case

5.38E-01 (Median) Methylation in Control 5.89E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

TSS1500 (cg07915221)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.37E+00 Statistic Test p-value: 8.58E-13; Z-score: -4.86E+00

Methylation in Case

6.06E-01 (Median) Methylation in Control 8.29E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

TSS1500 (cg09661503)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 6.85E-05; Z-score: -7.26E-01

Methylation in Case

8.47E-01 (Median) Methylation in Control 8.69E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

TSS1500 (cg14778922)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 2.25E-02; Z-score: -5.00E-01

Methylation in Case

6.19E-01 (Median) Methylation in Control 6.78E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

TSS200 (cg12355180)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 2.48E-11; Z-score: -1.21E+00

Methylation in Case

1.05E-01 (Median) Methylation in Control 1.35E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

TSS200 (cg16843423)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.84E+00 Statistic Test p-value: 5.19E-07; Z-score: 2.40E+00

Methylation in Case

1.24E-01 (Median) Methylation in Control 6.72E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

Body (cg03710889)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.24E+00 Statistic Test p-value: 3.43E-16; Z-score: 2.47E+00

Methylation in Case

7.34E-01 (Median) Methylation in Control 5.91E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

Body (cg03282975)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.49E+00 Statistic Test p-value: 2.21E-14; Z-score: -4.68E+00

Methylation in Case

5.41E-01 (Median) Methylation in Control 8.06E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

Body (cg13504844)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.43E+00 Statistic Test p-value: 3.71E-13; Z-score: -3.52E+00

Methylation in Case

4.45E-01 (Median) Methylation in Control 6.38E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

Body (cg14051368)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.41E+00 Statistic Test p-value: 2.33E-11; Z-score: -2.60E+00

Methylation in Case

2.72E-01 (Median) Methylation in Control 3.83E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

Body (cg22459052)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.19E+00 Statistic Test p-value: 3.00E-07; Z-score: 1.47E+00

Methylation in Case

5.65E-01 (Median) Methylation in Control 4.77E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

Body (cg02414785)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 1.07E-04; Z-score: -2.33E+00

Methylation in Case

5.72E-01 (Median) Methylation in Control 6.53E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC6A7 in hepatocellular carcinoma [ 7 ]

Location

3'UTR (cg18725599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 6.44E-06; Z-score: -9.90E-01

Methylation in Case

5.99E-01 (Median) Methylation in Control 6.56E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  HIV infection

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in HIV infection [ 8 ]

Location

TSS1500 (cg14778922)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.29E+00 Statistic Test p-value: 8.43E-05; Z-score: -1.16E+00

Methylation in Case

5.51E-01 (Median) Methylation in Control 7.11E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in HIV infection [ 8 ]

Location

TSS1500 (cg09588653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 2.29E-02; Z-score: -6.94E-01

Methylation in Case

7.32E-01 (Median) Methylation in Control 7.67E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in HIV infection [ 8 ]

Location

TSS200 (cg16843423)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.43E+00 Statistic Test p-value: 1.33E-03; Z-score: 1.08E+00

Methylation in Case

4.51E-02 (Median) Methylation in Control 3.15E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A7 in HIV infection [ 8 ]

Location

Body (cg15555712)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 8.06E-05; Z-score: -1.91E+00

Methylation in Case

6.75E-01 (Median) Methylation in Control 7.56E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A7 in HIV infection [ 8 ]

Location

Body (cg21212995)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 1.50E-04; Z-score: 6.65E-01

Methylation in Case

3.98E-01 (Median) Methylation in Control 3.70E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A7 in HIV infection [ 8 ]

Location

Body (cg11201401)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 2.42E-02; Z-score: 5.39E-01

Methylation in Case

5.06E-01 (Median) Methylation in Control 4.83E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A7 in HIV infection [ 8 ]

Location

3'UTR (cg08631357)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 5.21E-03; Z-score: 6.35E-01

Methylation in Case

3.36E-01 (Median) Methylation in Control 2.97E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A7 in HIV infection [ 8 ]

Location

3'UTR (cg18725599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 3.84E-02; Z-score: -6.54E-01

Methylation in Case

6.52E-01 (Median) Methylation in Control 6.75E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in lung adenocarcinoma [ 9 ]

Location

TSS1500 (cg09588653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 3.10E-02; Z-score: -1.77E+00

Methylation in Case

7.17E-01 (Median) Methylation in Control 7.81E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in lung adenocarcinoma [ 9 ]

Location

TSS200 (cg16843423)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.13E+00 Statistic Test p-value: 7.38E-03; Z-score: 6.53E+00

Methylation in Case

1.12E-01 (Median) Methylation in Control 5.25E-02 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in lung adenocarcinoma [ 9 ]

Location

Body (cg15555712)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 2.31E-05; Z-score: -2.80E+00

Methylation in Case

6.18E-01 (Median) Methylation in Control 7.06E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A7 in lung adenocarcinoma [ 9 ]

Location

Body (cg22459052)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.24E+00 Statistic Test p-value: 1.29E-02; Z-score: -1.61E+00

Methylation in Case

3.81E-01 (Median) Methylation in Control 4.70E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A7 in lung adenocarcinoma [ 9 ]

Location

Body (cg21212995)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.33E+00 Statistic Test p-value: 1.92E-02; Z-score: 1.76E+00

Methylation in Case

4.30E-01 (Median) Methylation in Control 3.22E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A7 in lung adenocarcinoma [ 9 ]

Location

Body (cg11201401)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 3.12E-02; Z-score: 1.78E+00

Methylation in Case

5.45E-01 (Median) Methylation in Control 4.51E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A7 in lung adenocarcinoma [ 9 ]

Location

3'UTR (cg18725599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 3.81E-04; Z-score: -2.58E+00

Methylation in Case

6.54E-01 (Median) Methylation in Control 7.31E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A7 in lung adenocarcinoma [ 9 ]

Location

3'UTR (cg08631357)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 2.10E-02; Z-score: -8.58E-01

Methylation in Case

5.22E-01 (Median) Methylation in Control 5.76E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Panic disorder

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in panic disorder [ 10 ]

Location

TSS1500 (cg09661503)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 1.99E-02; Z-score: 2.87E-01

Methylation in Case

2.53E+00 (Median) Methylation in Control 2.43E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in panic disorder [ 10 ]

Location

Body (cg22459052)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -9.76E-01 Statistic Test p-value: 1.65E-02; Z-score: -3.41E-01

Methylation in Case

-3.69E+00 (Median) Methylation in Control -3.60E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in panic disorder [ 10 ]

Location

Body (cg02414785)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 2.88E-02; Z-score: 3.44E-01

Methylation in Case

1.22E+00 (Median) Methylation in Control 1.05E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in papillary thyroid cancer [ 11 ]

Location

TSS1500 (cg09588653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.34E-02; Z-score: -1.55E-01

Methylation in Case

7.92E-01 (Median) Methylation in Control 8.00E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in papillary thyroid cancer [ 11 ]

Location

Body (cg21212995)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 2.85E-02; Z-score: 6.22E-01

Methylation in Case

1.87E-01 (Median) Methylation in Control 1.65E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in papillary thyroid cancer [ 11 ]

Location

Body (cg15555712)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 3.21E-02; Z-score: -4.28E-01

Methylation in Case

7.47E-01 (Median) Methylation in Control 7.72E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A7 in papillary thyroid cancer [ 11 ]

Location

3'UTR (cg18725599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 2.97E-02; Z-score: 1.57E-01

Methylation in Case

8.09E-01 (Median) Methylation in Control 8.02E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Systemic lupus erythematosus

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in systemic lupus erythematosus [ 12 ]

Location

TSS1500 (cg14778922)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 4.47E-02; Z-score: -1.75E-01

Methylation in Case

5.26E-01 (Median) Methylation in Control 5.61E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in systemic lupus erythematosus [ 12 ]

Location

Body (cg22459052)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 4.57E-02; Z-score: 7.31E-02

Methylation in Case

1.18E-01 (Median) Methylation in Control 1.17E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Prostate cancer

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in prostate cancer [ 13 ]

Location

TSS200 (cg24607642)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.38E+00 Statistic Test p-value: 1.49E-02; Z-score: 5.92E+00

Methylation in Case

7.73E-01 (Median) Methylation in Control 5.62E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in prostate cancer [ 13 ]

Location

1stExon (cg02192965)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.15E+00 Statistic Test p-value: 5.12E-03; Z-score: 2.60E+00

Methylation in Case

9.10E-01 (Median) Methylation in Control 7.93E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in prostate cancer [ 13 ]

Location

Body (cg22284058)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 8.35E-03; Z-score: 2.97E+00

Methylation in Case

8.64E-01 (Median) Methylation in Control 7.89E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A7 in prostate cancer [ 13 ]

Location

Body (cg01767396)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.64E+00 Statistic Test p-value: 9.49E-03; Z-score: 2.03E+00

Methylation in Case

6.72E-01 (Median) Methylation in Control 4.09E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A7 in prostate cancer [ 13 ]

Location

Body (cg04849842)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.85E+00 Statistic Test p-value: 3.04E-02; Z-score: 1.03E+01

Methylation in Case

5.56E-01 (Median) Methylation in Control 1.95E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A7 in prostate cancer [ 13 ]

Location

3'UTR (cg21941987)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 7.39E-03; Z-score: 2.44E+00

Methylation in Case

9.23E-01 (Median) Methylation in Control 8.23E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumor

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A7 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg02414785)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.61E-04; Z-score: -6.65E-01

Methylation in Case

9.11E-01 (Median) Methylation in Control 9.52E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A7 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg11201401)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 2.05E-02; Z-score: 4.81E-01

Methylation in Case

8.02E-01 (Median) Methylation in Control 7.52E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A7 in atypical teratoid rhabdoid tumor [ 14 ]

Location

3'UTR (cg08631357)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.33E+00 Statistic Test p-value: 7.14E-13; Z-score: -1.95E+00

Methylation in Case

5.62E-01 (Median) Methylation in Control 7.48E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A7 in atypical teratoid rhabdoid tumor [ 14 ]

Location

3'UTR (cg18725599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 1.77E-10; Z-score: -1.57E+00

Methylation in Case

7.19E-01 (Median) Methylation in Control 8.51E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Liver cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC6A7 in liver cancer than that in healthy individual

Studied Phenotype

Liver cancer [ICD-11:2C12]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 8.48E-16; Fold-change: 0.207191524; Z-score: 5.654076904
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Oligodendroglioma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC6A7 in oligodendroglioma than that in healthy individual

Studied Phenotype

Oligodendroglioma [ICD-11:2A00.0Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 7.19E-36; Fold-change: 0.228536979; Z-score: 3.654428315
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Posterior fossa ependymoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC6A7 in posterior fossa ependymoma than that in healthy individual

Studied Phenotype

Posterior fossa ependymoma [ICD-11:2D50.2]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 4.34E-119; Fold-change: 0.257230712; Z-score: 3.319899036
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Lymphoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC6A7 in lymphoma than that in healthy individual

Studied Phenotype

Lymphoma [ICD-11:2B30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 3.02E-15; Fold-change: 0.38898001; Z-score: 6.20144863
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
References
1 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
2 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
3 DNA Methylation Dynamics in Urological Tumors.
4 Genome-wide Scan for Methylation Profiles in Breast Cancer
5 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
6 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
7 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
8 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
9 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
10 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
11 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
12 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
13 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
14 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.